20504915|t|In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
20504915|a|Enhancement of alpha7 nicotinic acetylcholine receptor (nAChR) activity is considered a therapeutic approach for ameliorating cognitive deficits present in Alzheimer's disease and schizophrenia. In this study, we describe the in vitro profile of a novel selective alpha7 nAChR agonist, 5-(6-[(3R)-1-azabicyclo[2,2,2]oct-3-yloxy]pyridazin-3-yl)-1H-indole (ABT-107). ABT-107 displayed high affinity binding to alpha7 nAChRs [rat or human cortex, [(3)H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane (A-585539), K(i) = 0.2-0.6 nM or [(3)H]methyllycaconitine (MLA), 7 nM] that was at least 100-fold selective versus non-alpha7 nAChRs and other receptors. Functionally, ABT-107 did not evoke detectible currents in Xenopus oocytes expressing human or nonhuman alpha3beta4, chimeric (alpha6/alpha3)beta4, or 5-HT(3A) receptors, and weak or negligible Ca(2+) responses in human neuroblastoma IMR-32 cells (alpha3* function) and human alpha4beta2 and alpha4beta4 nAChRs expressed in human embryonic kidney 293 cells. ABT-107 potently evoked human and rat alpha7 nAChR current responses in oocytes (EC(50), 50-90 nM total charge, approximately 80% normalized to acetylcholine) that were enhanced by the positive allosteric modulator (PAM) 4-[5-(4-chloro-phenyl)-2-methyl-3-propionyl-pyrrol-1-yl]-benzenesulfonamide (A-867744). In rat hippocampus, ABT-107 alone evoked alpha7-like currents, which were inhibited by the alpha7 antagonist MLA. In dentate gyrus granule cells, ABT-107 enhanced spontaneous inhibitory postsynaptic current activity when coapplied with A-867744. In the presence of an alpha7 PAM [A-867744 or N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride (PNU-120596)], the addition of ABT-107 elicited MLA-sensitive alpha7 nAChR-mediated Ca(2+) signals in IMR-32 cells and rat cortical cultures and enhanced extracellular signal-regulated kinase phosphorylation in differentiated PC-12 cells. ABT-107 was also effective in protecting rat cortical cultures against glutamate-induced toxicity. In summary, ABT-107 is a selective high affinity alpha7 nAChR agonist suitable for characterizing the roles of this subtype in pharmacological studies.
20504915	63	111	alpha7 neuronal nicotinic acetylcholine receptor	Gene	1139
20504915	120	127	ABT-107	Chemical	MESH:C552256
20504915	144	183	alpha7 nicotinic acetylcholine receptor	Gene	1139
20504915	185	190	nAChR	Gene	1137
20504915	255	273	cognitive deficits	Disease	MESH:D003072
20504915	285	304	Alzheimer's disease	Disease	MESH:D000544
20504915	309	322	schizophrenia	Disease	MESH:D012559
20504915	393	405	alpha7 nAChR	Gene	
20504915	415	482	5-(6-[(3R)-1-azabicyclo[2,2,2]oct-3-yloxy]pyridazin-3-yl)-1H-indole	Chemical	-
20504915	484	491	ABT-107	Chemical	MESH:C552256
20504915	494	501	ABT-107	Chemical	MESH:C552256
20504915	537	550	alpha7 nAChRs	Gene	
20504915	552	555	rat	Species	10116
20504915	559	564	human	Species	9606
20504915	573	662	[(3)H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane	Chemical	-
20504915	664	672	A-585539	Chemical	MESH:C525870
20504915	696	720	[(3)H]methyllycaconitine	Chemical	-
20504915	722	725	MLA	Chemical	MESH:C054634
20504915	782	795	alpha7 nAChRs	Gene	
20504915	831	838	ABT-107	Chemical	MESH:C552256
20504915	876	883	Xenopus	Species	8355
20504915	903	908	human	Species	9606
20504915	1011	1017	Ca(2+)	Chemical	-
20504915	1031	1036	human	Species	9606
20504915	1037	1050	neuroblastoma	Disease	MESH:D009447
20504915	1051	1057	IMR-32	CellLine	CVCL:0346
20504915	1065	1071	alpha3	Gene	28883
20504915	1087	1092	human	Species	9606
20504915	1141	1146	human	Species	9606
20504915	1164	1167	293	CellLine	CVCL:0045
20504915	1175	1182	ABT-107	Chemical	MESH:C552256
20504915	1199	1204	human	Species	9606
20504915	1209	1212	rat	Species	10116
20504915	1213	1225	alpha7 nAChR	Gene	
20504915	1319	1332	acetylcholine	Chemical	MESH:D000109
20504915	1396	1471	4-[5-(4-chloro-phenyl)-2-methyl-3-propionyl-pyrrol-1-yl]-benzenesulfonamide	Chemical	-
20504915	1473	1481	A-867744	Chemical	MESH:C542089
20504915	1487	1490	rat	Species	10116
20504915	1504	1511	ABT-107	Chemical	MESH:C552256
20504915	1525	1531	alpha7	Gene	28885
20504915	1575	1581	alpha7	Gene	28885
20504915	1593	1596	MLA	Chemical	MESH:C054634
20504915	1630	1637	ABT-107	Chemical	MESH:C552256
20504915	1720	1728	A-867744	Chemical	MESH:C542089
20504915	1764	1772	A-867744	Chemical	MESH:C542089
20504915	1776	1844	N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride	Chemical	MESH:C498513
20504915	1846	1856	PNU-120596	Chemical	MESH:C508388
20504915	1876	1883	ABT-107	Chemical	MESH:C552256
20504915	1893	1896	MLA	Chemical	MESH:C054634
20504915	1929	1935	Ca(2+)	Chemical	-
20504915	1947	1953	IMR-32	CellLine	CVCL:0346
20504915	1964	1967	rat	Species	10116
20504915	2071	2076	PC-12	CellLine	CVCL:0481
20504915	2084	2091	ABT-107	Chemical	MESH:C552256
20504915	2125	2128	rat	Species	10116
20504915	2155	2164	glutamate	Chemical	MESH:D018698
20504915	2173	2181	toxicity	Disease	MESH:D064420
20504915	2195	2202	ABT-107	Chemical	MESH:C552256
20504915	Association	MESH:D012559	1137
20504915	Negative_Correlation	MESH:C508388	28885
20504915	Association	MESH:C498513	MESH:D064420
20504915	Association	MESH:C508388	MESH:D018698
20504915	Positive_Correlation	MESH:C552256	28885
20504915	Association	MESH:C498513	MESH:C508388
20504915	Positive_Correlation	MESH:C552256	1139
20504915	Association	MESH:D003072	1139
20504915	Association	MESH:D018698	MESH:D064420
20504915	Association	MESH:D003072	1137
20504915	Association	MESH:C508388	MESH:D064420
20504915	Association	MESH:D009447	28883
20504915	Association	MESH:D012559	1139
20504915	Negative_Correlation	MESH:C054634	28885
20504915	Association	MESH:D000544	1137
20504915	Association	MESH:C525870	MESH:C552256
20504915	Association	MESH:D000544	1139
20504915	Association	MESH:C498513	MESH:D018698
20504915	Negative_Correlation	MESH:C498513	28885

